Skip to content
Screener

Celanese Corporation CE Other Nonrecurring Income Expense

Other Nonrecurring Income Expense at other companies

Pitney Bowes logo
Pitney BowesPBI
$483K+107%
Vertex, Inc. logo
Vertex, Inc.VERX
$3.25M-0.4%
Celanese Corporation logo
Celanese CorporationCE
$31M+55.0%
Amgen logo
AmgenAMGN
$116M+50.6%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$246K-57.1%
Microchip Technology logo
Microchip TechnologyMCHP
$18.9M-14.9%

Segments

By segment

See full
Acetyl Chain$21M+2,000%
Engineered Materials$8M-50.0%
Other$2M-33.3%

Other financials

Income statement

See full
Revenue$2.8B+8.7%
Gross profit$618.0M+15.7%
Operating income$276.0M+19.5%
Net income$125.0M-36.5%
EPS (diluted)$1.13-37.2%

Balance sheet

See full
Cash & equivalents$1.4B+16.3%
Total debt$13.7B+1.9%
Total equity$4.2B-20.7%
Total assets$21.4B-9.7%

Cash flow

See full
Operating cash flow$209.0M-49.0%
CapEx$62.0M-33.3%
Free cash flow$147.0M-53.6%

Valuation

See full
Market cap$4.82B-7.2%
Enterprise value$17.2B-1.8%
P/S0.5×0.0×

Profitability

See full
Gross margin20.9%-0.8pp
Operating margin-23.7%-32.7pp
Net margin-12.2%-2.5pp
FCF margin7.3%+0.8pp

Returns & leverage

See full
Return on equity-25.2%-1.1pp
Debt / equity3.3×+0.7×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Celanese Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherNonrecurringIncomeExpense.

The source filing: Celanese Corporation’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:22 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001306830-26-000117
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Selling, general and administrative expenses(251)(214)(477)(445)
Amortization of intangible assets(39)(42)(79)(82)
Research and development expenses(29)(31)(57)(62)
Other (charges) gains, net(31)(20)(51)(51)
Foreign exchange gain (loss), net1062227
Gain (loss) on disposition of businesses and assets, net(2)(2)461
Operating profit (loss)276231490396
Equity in net earnings (loss) of affiliates11294651

Item 1. Financial Statements

FAQ

What is Celanese Corporation's other nonrecurring income expense?
Celanese Corporation (CE) reported other nonrecurring income expense of $31M in Q2 2026.
How has Celanese Corporation's other nonrecurring income expense changed year-over-year?
Celanese Corporation's other nonrecurring income expense increased by 55.0% year-over-year, from $20M to $31M.
What is the long-term trend for Celanese Corporation's other nonrecurring income expense?
Over 3 years (2021 to 2025), Celanese Corporation's other nonrecurring income expense has grown at a 707.7% compound annual growth rate (CAGR), from -$3M to $1.58B.
What does other nonrecurring income expense mean?
This metric represents gains or losses resulting from infrequent or unusual events that are not part of the company's core operating activities. It captures significant one-time items such as restructuring charges, asset impairments, or litigation settlements that impact net income but do not reflect ongoing business performance. Investors monitor this to adjust earnings for non-recurring volatility and assess the underlying profitability of the firm.

Ask your AI about Celanese Corporation's other nonrecurring income expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude